Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2020-09-16 2020-09-16
Drug Identification Number 02386348 02386348
Brand name SIMVASTATIN SIMVASTATIN
Common or Proper name SIMVASTATIN SIMVASTATIN
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients SIMVASTATIN SIMVASTATIN
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-09-15 2020-09-15
Actual start date
Estimated end date 2020-11-30 2020-11-30
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments